Danenberg Noam 4
4 · Wize Pharma, Inc. · Filed Dec 31, 2020
Insider Transaction Report
Form 4
Danenberg Noam
Chief Operating Officer
Transactions
- Sale
Common Stock
2020-12-29−1,447→ 2,741,498 total(indirect: See Footnote) - Exercise of In-Money
Common Stock
2020-12-29+173,607→ 2,742,945 total(indirect: See Footnote) - Exercise of In-Money
Warrant (right to buy)
2020-12-29−125,000→ 0 totalExercise: $0.16From: 2019-04-21Exp: 2023-10-23→ Common Stock (125,000 underlying) - Exercise of In-Money
Future Investment Rights
2020-12-29−63,236→ 0 total(indirect: See Footnote)Exercise: $0.27From: 2019-12-13Exp: 2024-12-12→ Common Stock (63,236 underlying) - Exercise of In-Money
Common Stock
2020-12-29+1,505,162→ 2,581,881 total(indirect: See Footnote) - Exercise of In-Money
Common Stock
2020-12-29+125,000→ 1,077,681 total - Exercise of In-Money
Common Stock
2020-12-29+63,236→ 2,804,734 total(indirect: See Footnote) - Sale
Common Stock
2020-12-29−962→ 1,076,719 total - Sale
Common Stock
2020-12-29−12,543→ 2,569,338 total(indirect: See Footnote) - Sale
Common Stock
2020-12-29−507→ 2,804,227 total(indirect: See Footnote) - Exercise of In-Money
Warrant (right to buy)
2020-12-29−1,505,162→ 0 total(indirect: See Footnote)Exercise: $0.27Exp: 2024-12-12→ Common Stock (1,505,162 underlying) - Exercise of In-Money
Warrant (right to buy)
2020-12-29−173,607→ 0 total(indirect: See Footnote)Exercise: $0.16From: 2019-05-31Exp: 2021-05-30→ Common Stock (173,607 underlying)
Footnotes (7)
- [F1]On December 23, 2020 the registrant has voluntary reduced the exercise price of warrants to $0.001. The reporting person exercised a warrant to purchase shares of the registrant's common stock for the reduced exercise price.
- [F2]On December 29, 2020 the reporting person exercised a warrant to purchase 125,000 shares of the registrant's common stock for $0.16 a share. The reporting person paid the exercise price on a cashless basis, resulting in the registrant withholding of 962 of the warrant shares to pay the exercise price and issuing to the reporting person the remaining 124,038 shares.
- [F3]On December 29, 2020 the reporting person exercised a warrant to purchase 1,505,162 shares of the registrant's common stock for $0.27 a share. The reporting person paid the exercise price on a cashless basis, resulting in the registrant withholding of 12,543 of the warrant shares to pay the exercise price and issuing to the reporting person the remaining 1,492,619 shares.
- [F4]On December 29, 2020 the reporting person exercised a warrant to purchase 173,607 shares of the registrant's common stock for $0.16 a share. The reporting person paid the exercise price on a cashless basis, resulting in the registrant withholding of 1,447 of the warrant shares to pay the exercise price and issuing to the reporting person the remaining 172,160 shares.
- [F5]On December 29, 2020 the reporting person exercised a warrant to purchase 63,236 shares of the registrant's common stock for $0.27 a share. The reporting person paid the exercise price on a cashless basis, resulting in the registrant withholding of 507 of the warrant shares to pay the exercise price and issuing to the reporting person the remaining 62,729 shares.
- [F6]Securities held by Mobigo Inc.
- [F7]Exercisable five days following the public announcement of positive clinical data results for LO2A.